LNCaP and C4-2 prostate cancer cells treated with taxanes
收藏官方服务：
资源简介：
LNCaP and C4-2 prostate cancer cells treated with taxanes
应用场景：
创建时间：
2015-01-01
相关数据集
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines. Homo sapiens
Human prostate cancer cell lines treated with androgen receptor (AR) agonists/antagonists and concurrent glucocorticoid receptor (GR) agonist/antagonists Overall design: Human prostate cancer cell lin
NIAID Data Ecosystem50
Different doses of androgens induce the expression of distinct gene expression programs (ATAC-Seq). Different doses of androgens induce the expression of distinct gene expression programs (ATAC-Seq)
Most prostate cancers express the androgen receptor (AR), and tumor growth and progression are facilitated by exceptionally low levels of systemic or intratumorally produced androgens. Paradoxically,
NIAID Data Ecosystem40
PC3 cells gene expression after p-coumaric acid treatment. PC3 cells gene expression after p-coumaric acid treatment
Whole genome expression monitoring of human adenocarcinoma prostate cancer (PC3) cell line, after sub-lethal treatment with p-coumaric acid Overall design: Treated vs untreated (control) cells, grown
NIAID Data Ecosystem50
Androgen-starved LNCaP cells treated with gedunin and androgen, androgen alone, or vehicle alone for 24h
Gedunin is a natural product that affects LNCaP androgen-signalling by 24h We used microarrays to detail the androgen-responsive program of gene expression affected by gedunin treatment at 24h Keyword
NIAID Data Ecosystem50
